Business Intelligence
The more generic alternatives there are to brand-name drugs, the more likely they will drive down costs for patients and providers. That's the word from a new report from the Journal of the American Medical Association.
The U.S. Department of Health and Human Services issued a report to Congress wherein it stated that HIPAA serves traditional healthcare well and continues to support national priorities for interoperable health information with its media-neutral privacy rule, but that the scope of HIPAA is limited.
Merger and acquisition activity in the healthcare industry is booming thanks to high valuations, a strong return on investment and opportunities to consolidate, and according to new research by Cascade Partners, this is increasingly true within physician practice management.
Cigna has launched CareAllies Inc., a new service company to help providers make the move to value-based care by easing their administrative burden across payers and even supporting the launch and management of their own health plans.
Rates of potentially preventable readmissions declined across all conditions between 2010 and 2014, according to a MedPAC analysis of Medicare claims data.
Eyeing fast-growing urban and suburban markets where demand for health care services is outstripping supply, some health care systems are opening tiny, full-service hospitals with comprehensive emergency services but often fewer than a dozen inpatient beds.
Three participating providers in Next Generation have dropped out, with two citing financial targets as the reason for the departure.
Hospital employment increased by 1.7 percent from May 2010 to May 2014, with physicians and surgeons leading the charge, their employment growing 25.5 percent over that time, according to a MedPAC analysis of Bureau of Labor statistics.
Backers of Montana's seven-month-old Medicaid expansion say they're pleased with the first set of financial data released this week.
Government spending on "compounded" drugs that are handmade by retail pharmacists has skyrocketed, drawing the attention of federal investigators who are raising fraud and overbilling concerns.